FDA Inspection 1236926 — Tasly Pharmaceuticals, Inc.
The FDA completed an inspection of Tasly Pharmaceuticals, Inc. on Apr 11, 2024 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 11, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Rockville, MD (United States)